The Devil Is in the Detailing

Executives who strive to improve the effectiveness and lower the costs of their businesses are often frustrated by the fact that they have run out of ideas. In fact, opportunities can often be uncovered by diving down to the details. In pharmaceutical industry, for instance, marketing efforts usually focus on physicians who prescribe higher volumes of drugs. However, an analysis of prescription data suggests pharmaceutical companies should focus on a more refined target: heavy prescribers who treat higher percentages of new patients, since patients are seldom switched to a different drug within a specific drug class, even if they switch doctors and the likelihood that a physician will choose the last drug prescribed for a patient is greater than 90%...


View the article